Search

everythinglearnresearchcommunity

for

Search:↓

Skin cancer in sun-exposed areas is more likely to come back.

The calcineurin/NFAT pathway plays a significant role in the development and growth of a type of skin cancer called cutaneous squamous cell carcinoma.

Bone marrow and hair follicle cells help form skin tumors, suggesting new treatment targets.

UVB exposure affects retinoid metabolism, which is important for skin cancer progression and treatment.

Patients with nonmelanoma skin cancers are most bothered by fear of progression, appearance concerns, and having cancer.

New skin lesions on the scrotum or vulva in patients with a history of internal cancer could indicate rare skin metastasis.

Alarmin cytokines are key in controlling skin immunity and inflammation.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

In Freixo de Espada à Cinta, common skin conditions include melanocytic nevi, hemangiomas, and acne, with variations based on age and sex.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

A cancer patient's eyelashes grew excessively without other common side effects after taking the cancer drug erlotinib.

Most cutaneous adnexal tumors examined were benign and resembled common skin tumors.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Protein kinase C epsilon may promote skin cancer development after UV exposure by affecting nearby cells.

A man with a rare scalp cancer was successfully treated, highlighting the need for early management to prevent spread and complications.

In Freixo de Espada à Cinta, many people have skin lesions, especially moles and acne.

Burn injuries can cause long-term itching, skin color changes, and cancer risks, needing personalized treatment.

Vascular patterns in dermoscopy help tell apart malignant and benign skin tumors.

No increased skin cancer risk was found in alopecia patients treated with photobiomodulation.

The number of new cases of cutaneous B-cell lymphoma has leveled off since the early 2000s, and survival rates have improved since 1973.

Nonmelanoma skin cancers have higher levels of certain osteopontin variants than normal skin.

Patients with cutaneous lupus erythematosus have a severely impaired quality of life, especially emotionally.

The document concludes that a better understanding of cell changes during wound healing could improve treatments for chronic wounds and other conditions.

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

KLF4 is important for maintaining skin stem cells and helps heal wounds.

Botulinum toxin injections effectively relieve pain from cutaneous leiomyomas.

Melatonin may benefit skin health and could be a promising treatment in dermatology.

Photodynamic therapy successfully treated skin cancer in a 53-year-old woman.

Bone marrow-derived cells contribute to skin tumors, suggesting new treatment targets for non-melanoma skin cancers.